Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240,356,213
-
Total 13F shares
-
92,027,552
-
Share change
-
+9,370,514
-
Total reported value
-
$1,549,738,036
-
Put/Call ratio
-
28%
-
Price per share
-
$16.84
-
Number of holders
-
162
-
Value change
-
+$162,565,361
-
Number of buys
-
105
-
Number of sells
-
62
Institutional Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q3 2024
As of 30 Sep 2024,
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,027,552 shares.
The largest 10 holders included
True Wind Capital Management, L.P., FMR LLC, MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, Nine Ten Capital Management LLC, Clal Insurance Enterprises Holdings Ltd, CROSSLINK CAPITAL INC, Voss Capital, LP, Pertento Partners LLP, and Phoenix Financial Ltd..
This page lists
162
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.